LYSTHENON

This brand name is authorized in Austria, Estonia, Lithuania, Malta, Romania, Turkey

Active ingredients

The drug LYSTHENON contains one active pharmaceutical ingredient (API):

1 Suxamethonium
UNII I9L0DDD30I - SUCCINYLCHOLINE CHLORIDE

Suxamethonium is a short-acting depolarising neuromuscular blocking agent. Suxamethonium inhibits neuromuscular transmission by depolarising the motor end plates in skeletal muscle.

Read about Suxamethonium

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
M03AB01 Suxamethonium M Musculo-skeletal system → M03 Muscle relaxants → M03A Muscle relaxants, peripherally acting agents → M03AB Choline derivatives
Discover more medicines within M03AB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1014332
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1019806, 1089072
Country: MT Medicines Authority Identifier(s): AA565/80501
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W61717001, W61717002
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699638754540

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.